Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencySun, 02 Jun 2024 08:31:43 +0200Thu, 30 May 2024 16:26:00 +0200Human medicines European public assessment report (EPAR): Tecartus, Brexucabtagene autoleucel, Date of authorisation: 14/12/2020, Revision: 8, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/tecartusHuman medicines European public assessment report (EPAR): Tecartus, Brexucabtagene autoleucel, Date of authorisation: 14/12/2020, Revision: 8, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/tecartusThu, 30 May 2024 16:26:00 +0200Human medicineTecartus : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5102-en_3.pdfTecartus : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5102-en_3.pdfThu, 30 May 2024 16:23:00 +0200Human medicine